Higher ERAP1 values (targeted by tosedostat) were shown to be associated with lower plasma PC values and HF risk, is targeted by cancer drug tosedostat, and plays a role in blood pressure regulation [59]. This evidence concerns the gene ERAP1 and hydrops fetalis.